Bromocriptine and psychosis: A literature review
- Cite this article as:
- Boyd, A. Psych Quart (1995) 66: 87. doi:10.1007/BF02238717
Bromocriptine is an ergot-derived dopamine agonist. Its current uses include the treatment of Parkinson's disease, postpartum ablaction, prolactionmas, acromegaly, and amenorrhea and galactorrhea secondary to neuroleptic use. It is often reported to produce psychiatric side effects such as confusion, hallucinations, and delusions. The literature is reviewed and supports a strong anecdotal relationship between bromocriptine use and psychosis.